Implant-Associated Cancers: A Look Beyond BIA-ALCL
Recent and upcoming case reports suggest possible cases of gluteal and other implant-associated ALCLs, raising questions about the cancer risk across all types of implants.
Lymphoma
LYMPHOMA ADVISOR
FEATURED CONTENT
-
-
Ibrutinib Shown to Cross the Blood-Brain Barrier in CNS Lymphoma
The authors proved that the drug was able to cross the blood-brain barrier in a concentration that was effective. -
Previously Hidden FDA Data Reveal a Multitude of Adverse Events Linked to Breast Implants
Why were adverse events reported through an alternative reporting channel as opposed to a more transparent means? -
Real-World Data in the Era of Precision Medicine for Lymphoid Malignancies
The use of real-world data shows promise in guiding the development of management strategies for lymphoid malignancies. -
Axi-Cel Moves Toward the First-Line Setting for High-Risk Large B-Cell Lymphoma
Are patients who have received fewer prior medications better candidates for the receipt of CAR-T therapies?
VIDEO SERIES
LYMPHOMA NEWS
A Decade of Treatments Administered to Elderly Patients With Hodgkin Lymphoma at a Single Center: New Insights
Use of Interim PET/CT to Stratify Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
Incidence of GI Adverse Events Associated With CAR-T Therapy for Lymphoma or Leukemia Is Low
Consensus Opinion Addresses Concerns About Clinical Application of CAR-T
M7-FLIPI Score Not Predictive of Outcomes in Chemo-Free Regimens for Follicular Lymphoma
Want to read more?
Please login or register first to view this content.
